Treanda Treats Rare Cancer (HealthDay)
Date : 2008 03 20 Category : Health
HealthDay - THURSDAY, March 20 (HealthDay News) -- The Cephalon drug Treanda
(bendamustine hydrochloride) has been approved by the U.S. Food and Drug
Administration to treat chronic lymphocytic leukemia, a rare cancer that
affects the blood and bone marrow.